Talk:Posterior reversible encephalopathy syndrome
 | This article is rated C-class on Wikipedia's content assessment scale. It is of interest to the following WikiProjects: | |||||||||||||
| ||||||||||||||
 | Ideal sources for Wikipedia's health content are defined in the guideline Wikipedia:Identifying reliable sources (medicine) and are typically review articles. Here are links to possibly useful sources of information about Posterior reversible encephalopathy syndrome.
|
MRIs
editMost of the article consisted of an MRI dataset. I'm not sure if there is any point in showing all the images. I'm moving it here for the time being. JFW | T@lk 20:39, 13 April 2009 (UTC)
Expanding
editI've picked some recent sources that would be useful for further expansion. The Garg paper and the Pula paper are fairly good, but for the neuroradiological discussions I think we should also cite these (both by Bartynski): PMID 18356474 and PMID 18403560, and think about touching on PMID 18268188 (recent large case series). JFW | T@lk 20:52, 13 April 2009 (UTC)
Medications
editRytyho usa (talk · contribs) added the following list of medicines associated with PRES, but omitted a source. Apart from the fact that we should be avoiding bullet-point lists, there was no source and some are implausible (like dexamethasone).
- Bevacizumab
- Cisplatin
- Cyclosporin A
- Cytarabine
- Dexamethasone
- Gemcitabine
- Interferon alpha
- Methotrexate
- Rituximab
- Sorafenib
- Tacrolimus
A source would resolve this issue. JFW | T@lk 09:01, 24 May 2013 (UTC)
- Jfdwolff (talk · contribs), here is the source I used for that information:
- Rajasekhar, A. (2007 Nov). "Gemcitabine-Induced Reversible Posterior Leukoencephalopathy Syndrome: A Case Report and Review of the Literature". The Oncologist. 12 (11): 1332–1335. doi:10.1634/theoncologist.12-11-1332. PMID 18055853.
{{cite journal}}: Check date values in:|date=(help); Unknown parameter|coauthors=ignored (|author=suggested) (help)
- Rajasekhar, A. (2007 Nov). "Gemcitabine-Induced Reversible Posterior Leukoencephalopathy Syndrome: A Case Report and Review of the Literature". The Oncologist. 12 (11): 1332–1335. doi:10.1634/theoncologist.12-11-1332. PMID 18055853.
- Not a great source, I'm affraid. This table is from a secondary source. Should we use that instead? JFW | T@lk 20:17, 24 June 2013 (UTC)
Lancet Neurol review
editdoi:10.1016/S1474-4422(15)00111-8 JFW | T@lk 18:25, 12 January 2016 (UTC)
- Histopathology: doi:10.1093/jnen/nlx112 JFW | T@lk 15:39, 6 May 2020 (UTC)
- doi:10.1016/j.jns.2019.07.018 focuses on imaging. JFW | T@lk 15:39, 6 May 2020 (UTC)
- doi:10.1097/WCO.0000000000000640 - general review. JFW | T@lk 15:39, 6 May 2020 (UTC)
Additional source
editdoi:10.1136/practneurol-2021-003194 JFW | T@lk 09:05, 29 May 2023 (UTC)